Publicaciones en las que colabora con José Manuel Vázquez Rodríguez (40)

2024

  1. lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction

    PLoS ONE, Vol. 19, Núm. 5 May

2022

  1. Rare Variants in Genes of the Cholesterol Pathway Are Present in 60% of Patients with Acute Myocardial Infarction

    International Journal of Molecular Sciences, Vol. 23, Núm. 24

2021

  1. Balloon-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprostheses: clinical and echocardiographic long-term outcomes

    Interactive Cardiovascular and Thoracic Surgery, Vol. 33, Núm. 2, pp. 173-180

  2. Economic evaluation of complete revascularization versus stress echocardiography-guided revascularization in the STEACS with multivessel disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1055-1062

  3. Spontaneous coronary artery dissection: Revascularization or conservative management?

    Archivos de Cardiologia de Mexico

2020

  1. Impact of covid-19 outbreak and public lockdown on st-segment elevation myocardial infarction care in Spain

    Cardiology Journal

  2. Impacto de la implementación de un programa de cateterismo ambulatorio en un centro de alto volumen

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 317-317

  3. Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 10

2018

  1. Automatic multiscale vascular image segmentation algorithm for coronary angiography

    Biomedical Signal Processing and Control, Vol. 46, pp. 1-9

  2. Efficacy and safety of transcatheter valve-in-valve replacement for Mitroflow bioprosthetic valve dysfunction

    Journal of Cardiac Surgery, Vol. 33, Núm. 7, pp. 356-362

  3. Value of the coronary artery disease consortium rule in patients with acute chest pain and negative troponins referred for exercise stress testing

    European Journal of Emergency Medicine, Vol. 25, Núm. 3, pp. 178-184

2015

  1. Temporal changes intheuse andresults ofexercise echocardiography

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 11, pp. 1207-1212

  2. Trends in referral patterns, invasive management, and mortality in elderly patients referred for exercise stress testing

    European Journal of Internal Medicine, Vol. 26, Núm. 10, pp. 787-791

2014

  1. Long-term prognostic value of mitral regurgitation in patients with st-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 113, Núm. 6, pp. 907-912

2013

  1. Long-term prognostic benefit of field triage and direct transfer of patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

    American Journal of Cardiology, Vol. 111, Núm. 12, pp. 1721-1726

2012

  1. Angioplastia primaria en el Área Norte de Galicia: cambios asistenciales y resultados tras la implantación del programa PROGALIAM

    Revista Espanola de Cardiologia, Vol. 65, Núm. 4, pp. 341-349

  2. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI

    Revista Espanola de Cardiologia, Vol. 65, Núm. 3, pp. 227-233

  3. Renal insufficiency and vascular complications after primary angioplasty via femoral route. Impact of vascular closure devices use

    Revista Espanola de Cardiologia, Vol. 65, Núm. 3, pp. 258-264

2011

  1. Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

    American Heart Journal, Vol. 161, Núm. 6, pp. 1207-1213